Company intelligence / Profile preview

Enable Biosciences

South San Francisco, California, United Statesenablebiosciences.com ↗

Ownership: Private
Employees: ~30
Development stage: Commercial

Overview

Enable Biosciences has developed and commercialized an ultrasensitive immunoassay platform using agglutination-PCR ("ADAP") for early detection of autoantibodies. Their technology enables earlier diagnosis of type 1 diabetes and other autoimmune/infectious diseases by detecting antibodies at extremely low concentrations. Over 150,000 tests have been performed globally; the company recently secured new patents supporting its leadership in predictive diagnostics.

Therapeutic areas: EndocrinologyImmunologyInfectious Diseases
Modalities: Diagnostic device (immunoassay)DNA-barcoding antibody detection technology (ADAP)Molecular diagnostic platform
Industry: Protein Biomarker Diagnostics

Partnerships

Stanford HealthcareHarvard Medical SchoolCalifornia Department of Public HealthJuvenile Diabetes Research Foundation/JDRF

Beyond the preview

Go deeper on Enable Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Enable Biosciences.

Explore the full profile